These results demonstrated that the knockdown of CANX significantly enhances the ability of TMZ to suppress GBM cell growth and prolong survival, suggesting that the inhibition of CANX expression can effectively augment the antitumor effect of TMZ in glioma. Here, CANX is linked to central nervous system cancer.